Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When is this pos going to do something?
Which week is that? Sorry.
Bought SPCE Feb 5 40 calls yesterday morning at 1.06. Currently at 5.90. ??
Of course the Dems will blame this on Trump.
It's on TDA
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Chembio Diagnostics, Inc. (CEMI)
12:00pm ET 7/31/2020 Globe Newswire
Mentioned in article
CEMI
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming August 17, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Chembio Diagnostics, Inc. ("Chembio" or the "Company") (NASDAQ: CEMI) common stock between March 12, 2020 and June 16, 2020, inclusive (the "Class Period").
If you suffered a loss on your Chembio investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/chembio-diagnostics-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
In April 2020, the Company's COVID-19 antibody test was one of the first to be granted Emergency Use Authorization ("EUA") by the U.S. Food and Drug Administration ("FDA").
Then, on June 17, 2020, before the market opened, the FDA revoked the EUA for Chembio's Dual Path Platform COVID-19 serology test due to concerns regarding the test's accuracy. Specifically, the FDA found that the "benefits no longer outweigh its risks" and that "it is not reasonable to believe that the test may be effective" because it "generates a higher than expected rate of false results and higher than that reflected in the authorized labeling for the device."
On this news, the Company's share price fell $6.04, or nearly 60%, to close at $3.89 per share on June 17, 2020.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you purchased or otherwise acquired Chembio common stock during the Class Period, you may move the Court no later than August 17, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
https://ml.globenewswire.com/media/dca1d463-f40e-41ea-a1d6-f8a47b633445/small/gpm-logo-jpg.jpg
comtex tracking
CEMI. curling up looking to fill the gap at $8
It would probably be better for the stock to stay in this area and consolidate. It needs a rest.
$32 and counting premarket... wow
I bought calls this morning. TDA. No problem.
WMT...wth?
They were supposed to announce earnings on Wednesday but i have yet to see it.
Good morning. Thank you for that explanation...
What will happen to USO options in relation to the r/s? Will they because worthless?
I'm short. Making a killing...
Buying all the puts. Correct
Hey all. New to this board.
Looking to dip my toes into this options thing. I 've been studying and researching and i feel i have a good grasp on things. Anyway, I'm looking at AZO. Big fall on Friday. Closed at 728 and I'm thinking it will get back up around 800 this week. I want to buy 910 strike call at 6.40. Any opinions would be appreciated. Thanks.
The wedge was why i bought this morning.
If you don't like this company, why are you even here?
Because they don't want you to have them. MMs playing games.
36k. Not much compared to others here.
DFCO
If you think it's going to be a 10 bagger from here why sell any shares?
A good thing is there isn't a gap up from the open.
3.9M ÷ 47.2M shares= .08 a share. That is only for one quarter. Project that out to a full year...
How much do these filings cost and who pays for them if the company has no money?
50 million+ traded last four days...
Something has leaked...
Got a buy order in at .80
That is true in most cases. However, and i could be wrong, i don't think there will be news before opening bell Monday, giving the MMs time to hold it down a little longer. I want this to go back to $40 share like everyone else, but just trying to be realistic.
It will fill the gap from .75 while waiting on news, possibly opening in that range.
It has to fill the gap first.
But order in at .75. That gap well be closed.
$10 a share is 430m not 4.3...
Sold at .95 this afternoon. $1.00 seems to be resistance plus it needs to fill the opening gap from this morning.
I can in no way imagine the common shares being cancelled as Lampert owns 49%of them.
This list is probably incomplete. The store in Fayetteville N.C., where I live, closed this month also
Lol. Not giving them away for that. Good day sir.
Why do you say that? I'm not trolling or lying. I have offered no opinion for either side.